Latest revenue
$1.59B
as of 2026-03-31
Latest net income
$194.5M
as of 2026-03-31
Net margin
12.3%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $10.41B
- Enterprise value
- $10.41B
- P/E (trailing)
- 18.4×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.7%
- 52-wk high
- $127.99
- 52-wk low
- $92.77
- Beta
- —
- Shares out
- 99.2M
5-year trend
What this company does
Item 1.Business Overview of the Company General We are the nation’s largest owner and operator of inpatient rehabilitation hospitals in terms of patients treated, revenues, and number of hospitals. We provide specialized rehabilitative treatment, using advanced technology and intensive therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence and quality of life. We operate hospitals in 39 states and Puerto Rico, with concentrations in Florida and Texas. As of December 31, 2025, we operated 173 inpatient rehabilitation hospitals. We are committed to delivering high-quality, cost-effective patient care. For…
AI summary unavailable — showing raw filing excerpt
Generated from EHC's filing dated 2026-02-26
Key risks
Item 1A.Risk Factors Our business, operations, and financial position are subject to various risks. Some of these risks are described below, and the reader should take such risks into account in evaluating Encompass Health or any investment decision involving Encompass Health. This section does not describe all risks that may be applicable to us, our industry, or our business, and it is intended only as a summary of material risk factors. More detailed information concerning other risks and uncertainties as well as those described below is contained in other sections of this annual report. Still other risks and uncertainties we have not or cannot foresee as material to us may also adversely…
AI summary unavailable — showing raw filing excerpt
Generated from EHC's filing dated 2026-02-26
Profitability
Net margin
9.5%
12.5%Return on equity
23.2%
5.3%Return on assets
8.0%
14.5%Leverage
Debt / equity
1.91×
11.7%Long-term debt / equity
1.00×
12.1%Debt / assets
65.6%
4.0%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $1.59B | +9.0% | $194.5M | +28.4% | 12.3% |
Q4 2025 2025-12-31 | $1.54B | +9.9% | $146.1M | +20.8% | 9.5% |
Q3 2025 2025-09-30 | $1.48B | +9.4% | $126.5M | +16.9% | 8.6% |
Q2 2025 2025-06-30 | $1.46B | +12.0% | $142.1M | +24.5% | 9.7% |
Q1 2025 2025-03-31 | $1.46B | +10.6% | $151.5M | +34.7% | 10.4% |
Q4 2024 2024-12-31 | $1.41B | — | $120.9M | — | 8.6% |
Q3 2024 2024-09-30 | $1.35B | +11.9% | $108.2M | +26.8% | 8.0% |
Q2 2024 2024-06-30 | $1.30B | +9.6% | $114.1M | +24.8% | 8.8% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Hospitals · SIC 8060
Your notes
Keep private notes on EHC — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$21.5M
Net activity
−$21.5M
Distinct insiders
4
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns EHC
Institutional value
$4.54B
Total shares held
49.5M
Distinct holders
384
As of
2026-03-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.8M | $1.04B | — | New |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.0M | $479.7M | — | New |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5M | $432.0M | — | New |
| 4 | Invesco Ltd. | 3.4M | $327.5M | — | New |
| 5 | DIMENSIONAL FUND ADVISORS LP | 1.7M | $162.0M | — | New |
| 6 | JPMORGAN CHASE & CO | 1.2M | $120.1M | — | New |
| 7 | Sumitomo Mitsui Trust Group, Inc. | 929.3K | $89.9M | — | New |
| 8 | Copeland Capital Management, LLC | 892.8K | $86.4M | — | New |
| 9 | Bank of New York Mellon Corp | 865.5K | $83.7M | — | New |
| 10 | FRANKLIN RESOURCES INC | 843.8K | $81.6M | — | New |
| 11 | Capital Research Global Investors | 813.7K | $78.7M | — | New |
| 12 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 803.2K | $77.7M | — | New |
| 13 | Allianz Asset Management GmbH | 770.8K | $74.6M | — | New |
| 14 | VANGUARD FIDUCIARY TRUST CO | 623.7K | $60.3M | — | New |
| 15 | JENNISON ASSOCIATES LLC | 579.0K | $56.0M | — | New |
| 16 | LOS ANGELES CAPITAL MANAGEMENT LLC | 532.6K | $51.5M | — | New |
| 17 | SEI INVESTMENTS CO | 508.9K | $49.2M | — | New |
| 18 | UBS Group AG | 496.1K | $48.0M | — | New |
| 19 | TD ASSET MANAGEMENT INC | 453.6K | $43.9M | — | New |
| 20 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 446.4K | $43.2M | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once EHC's latest filing finishes processing.